PERTH, Australia, 25th October 2017: Phylogica Limited (ASX:PYC) (Phylogica or the Company), developer of a leading intracellular drug delivery platform technology, is pleased to update shareholders on progress made during the September quarter in validating the platform technology and progressing specific cargoes.
Conference call details
Shareholders are invited to join a conference being held at 11.30am AEST / 8.30am AWST on Thursday October 26, hosted by CEO, Stephanie Unwin and CSO, Dr Robert Hayes, to discuss activity during the quarter, followed by Q&A with participants.
For further information please download PDF attached:
Download this document
